|
|
| |
|
ULUSLARARASI YAYINLAR |
|
Erdem H, Pay S, Serdar M, Simsek
I, Dinc A, Musabak U, Pekel A, Turan M. Different ELR (+)
angiogenic CXC chemokine profiles in synovial fluid of patients with
Behcet's disease, familial Mediterranean fever, rheumatoid arthritis, and
osteoarthritis.
Rheumatol Int. 2004 Nov 3 |
|
Turkish FMF Study Group. Familial Mediterranean Fever (FMF)
in Turkey: Results of a Nationwide Multicenter Study.
Medicine (Baltimore). 2005 Jan;84(1):1-11. |
|
Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY,
Inal A, Tuzun A, Erdil A, Bagci S. Does immune activation
continue during an attack-free period in familial Mediterranean fever?
Clin Exp Immunol. 2004 Dec;138(3):526-33. |
|
Yesilova Z, Pay S, Oktenli C, Musabak U, Saglam K, Sanisoglu SY, Dagalp K,
Erbil MK, Kocar IH. Hyperhomocysteinemia in patients with
Behcet's disease: is it due to inflammation or therapy?
Rheumatol Int. 2004 Apr 1 |
|
Dinc A, Takafuta T, Jiang D, Melikoglu M, Saruhan-Direskeneli G, Shapiro
SS. Anti-endothelial cell antibodies in Behcet's disease.
Clin Exp Rheumatol. 2003 Jul-Aug;21(4 Suppl 30):S27-30. |
|
Pay S, Terkeltaub R.
Calcium pyrophosphate dihydrate and hydroxyapatite
crystal deposition in the joint: new developments relevant to the
clinician. Curr Rheumatol Rep. 5:235-243, 2003. |
|
Pay S, Terkeltaub AR.
The case for uricase in gout.
Curr Rheumatol Rep. 2003 Jun;5(3):213-4 |
|
Apras S, Ertenli I, Ozbalkan Z, Kiraz S, Ozturk MA, Haznedaroglu IC,
Cobankara V, Pay S, Calguneri M.
Effects of
oral cyclophosphamide and prednisolone therapy on the endothelial functions
and clinical findings in patients with early diffuse systemic sclerosis.
Arthritis Rheum. 48:2256-2261, 2003 |
|
Aslan H, Pay S, Gok F, Baykal Y, Yilmaz MI, Sengul A, Aydin HI.
Antiannexin V autoantibody in thrombophilic Behcet's
disease.
Rheumatol Int. 2003 Dec 5 |
|
Ozturk M, Mas MR, Yasar M, Akay C, Aydogan H, Deveci S, Comert B, Simsek I,
Mas N, Kocar IH. The role of inducible
nitric oxide synthase inhibitor, meropenem, and taurine in experimental
acute necrotizing pancreatitis.
Pancreas. 2003 May;26(4):357-62. |
|
Calguneri M, Cobankara V, Ozatli D, Guler G, Apras S, Pay S, Kiraz S,
Ertenli I, Ozturk MA.
Is visual loss due to giant cell arteritis
reversible? Yonsei Medical Journal 44:155-158, 2003 |
|
Pay S, Erdem H, Serdar M, Dinc A, Simsek I, Turan M.
Comparison of Synovial MMP-1 and TIMP-1 Levels in Patients with
Various Inflammatory Arthritides: Is There Any Difference Between
Rheumatoid Arthritis, Behçet’s Disease and Familial Mediterranean Fever?
Clinical Rheumatology 21:511-515, 2002 |
|
Saglamkaya U, Mas MR, Yasar M, Simsek I, Mas NN, Kocabalkan F.
Penetration of meropenem and cefepim into pancreatic tissue during the
course of experimental acute pancreatitis.
Pancreas. 2002 Apr;24(3):264-8. |
|
Comert B, Mas MR, Erdem H, Dinc A,
Saglamkaya U, Cigerim M, Kuzhan O, Unal T, Kocabalkan F.
Insulin resistance in non-alcoholic steatohepatitis. Dig Liver Dis. 2001
May;33(4):353-8. |
|
H. ERDEM, K. SAĞLAM, M.İ.
YILMAZ, M. GÜLEÇ, F. BULUCU.
The investigation of Insulin Resistance with Hyperinsulinemic Euglycemic Clamp Technique in Premature Coronary Artery
Disease. International Journal of Medicine, Biology and the Enviroment.Vol
29 (1) 2001 |
|
Dinc A, Melikoglu M, Korkmaz C, Fresko I, Ozdogan H, Yazici H.
Nailfold capillary abnormalities in patients with familial Mediterranean
fever.
Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S42-4. |
|
Simsek I, Mas MR, Yasar M, Ozyurt M, Saglamkaya U, Deveci S, Comert B,
Basustaoglu A, Kocabalkan F, Refik M. Inhibition of inducible
nitric oxide synthase reduces bacterial translocation in a rat model of
acute pancreatitis.
Pancreas. 2001 Oct;23(3):296-301. |
|
Mas MR, Simsek I, Can C, Ateskan U, Erdem H, Kocabalkan F.
Fulminant hepatic failure as the initial manifestation of primary
hepatocellular carcinoma.
Eur J Gastroenterol Hepatol. 2000 May;12(5):575-8. |
|
Dinc A, Karaayvaz M, Caliskaner AZ, Pay S, Erdem H, Turan M.
Dermographism and Atopy in Patients with Behçet’s Disease.
Journal of Allergology and Clinical Immunology 10:368-371, 2000. |
|
Pay S, Dinc A, Simsek I, Can C, Erdem H.
Sulphasalazine
induced angioimmunoblastic lymphadenopathy. Rheumatology International 20:
25-27, 2000. |
|
Dinc A, Simsek I, Pay S, Caglar K, Can C.
Fabry’s Disease
mimicking Familial Mediterranean Fever. Clinical and Experimental
Rheumatology 18: 787-788, 2000. |
|
Dinc A, Soy M, Pay S, Simsek I, Erdem H, Sobaci G.
Case of Churg-Strauss
Syndrome presenting with cortical blindness. Clinical Rheumatology 19:
318-320, 2000. |
|
Pay S, Calguneri M, Caliskaner Z, Dinc A, Apras S, Ertenli I, Kiraz S,
Cobankara V.
Evaluation of Vascular Injury
with Proinflammatory Cytokines, Thrombomodulin and Fibronectin in Patients
with Primary Fibromyalgia. Nagoya Journal of Medical Science 63: 115-122,
2000. |
|
Dinc
A.
Non-periodic leg pain in patients with familial Mediterranean fever.
Ann Rheum Dis. 2000 May;59(5):400.
|
|
Simsek
I, Dinc A, Mas MR, Gunhan O, Kocabalkan F.
Behcet's disease with a cecal perforation.
Clin Exp Rheumatol. 2000 Mar-Apr;18(2):268-9. No abstract
available
|
|
Calguneri M, Pay S, Caliskaner Z, Apras S, Kiraz S, Ertenli I, Cobankara V.
Combination therapy versus monotherapy for the treatment of patients with
rheumatoid arthritis. Clinical and Experimental Rheumatology 17: 699-704,
1999. |
|
Kiraz S, Ertenli I, Arici M, Calguneri M, Haznedaroglu I, Celik I, Pay S,
Kirazli S.
Effects of colchicine on
inflammatory cytokines and selectins in familial Mediterranean fever.
Clinical and Experimental Rheumatology 16: 721-724, 1998 |
|
Mas MR, Saglamkaya U, Kubar A, Colakoglu M, Ateskan U, Erdem H, Nalbant S,
Eyileten T, Comert B, Unal T, Kocabalkan F. Hepatitis G virus
infection among patients undergoing hemodialysis.
Nephron. 1998 Oct;80(2):247-8.
|
|
Kocar
IH, Caliskaner Z, Pay S, Turan M.
Clostridium difficile
infection in patients with reactive arthritis of undetermined etiology.
Scandinavian Journal of Rheumatology 27: 357-362, 1998
|
|
Ozturk
E, Gunalp B, Mas R, Ozguven M, Dinc A, Bayhan H.
Evaluation of hepatocyte function after extracorporeal shock wave
lithotripsy with hepatobiliary scintigraphy.
Am J Gastroenterol. 1998 Oct;93(10):1905-8. |
|
Pay S, Ozcan N, Tokgozoglu SL.
Elevated Lp(a) is the most
frequent familial lipoprotein disorder leading to premature myocardial
infarction in a country with low cholesteol levels. International Journal
of Cardiology 60: 301-305, 1997. |
|
|